Skip to the page

Data / Drug companies / Aurisco Pharmaceutical Co.,Ltd

Aurisco Pharmaceutical Co.,Ltd: 30 products in the FDA NDC directory, labeler code 16812

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Aurisco Pharmaceutical Co.,Ltd (labeler code 16812) lists 30 products in the FDA National Drug Code Directory. By type: 30 bulk ingredients. Its main marketing category is bulk ingredients for compounding. The newest product started marketing on July 1, 2026.

The request: Watch Aurisco Pharmaceutical Co.,Ltd (FDA labeler code 16812): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
16812
Products in commercial distribution
30
Packages
31
Finished drugs by generic name
0
Prescription products
0
Over the counter products
0
Controlled substance products
Schedule V 2
Started marketing in the last 12 months
6
Earliest marketing start
January 1, 2020
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Bulk ingredients for compounding1756.7%
Bulk ingredients1343.3%

Products by type

TypeProductsShare
Bulk ingredients30100%

Dosage forms

Dosage formProductsShare
Powder30100%

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Tirzepatide16812-104PowderBulk ingredients for compoundingJuly 1, 2026
Estradiol hemihydrate16812-107PowderBulk ingredientsApril 5, 2026
Estradiol hemihydrate16812-107PowderBulk ingredientsApril 5, 2026
Estradiol hemihydrate16812-107PowderBulk ingredientsApril 5, 2026
Clascoterone16812-102PowderBulk ingredientsJanuary 1, 2026
Brivaracetam16812-009PowderBulk ingredientsJanuary 1, 2026
Semaglutide16812-103PowderBulk ingredients for compoundingMarch 15, 2025
Semaglutide16812-103PowderBulk ingredients for compoundingMarch 15, 2025
Semaglutide16812-103PowderBulk ingredients for compoundingMarch 15, 2025
Semaglutide16812-103PowderBulk ingredients for compoundingMarch 15, 2025
Tirzepatide16812-104PowderBulk ingredients for compoundingOctober 16, 2024
Tirzepatide16812-104PowderBulk ingredients for compoundingOctober 16, 2024
Tirzepatide16812-104PowderBulk ingredients for compoundingOctober 16, 2024
Tirzepatide16812-104PowderBulk ingredients for compoundingOctober 16, 2024
Tirzepatide16812-104PowderBulk ingredients for compoundingOctober 16, 2024
Tirzepatide16812-104PowderBulk ingredients for compoundingOctober 16, 2024
Tirzepatide16812-104PowderBulk ingredients for compoundingOctober 16, 2024
Tirzepatide16812-104PowderBulk ingredients for compoundingOctober 16, 2024
Tirzepatide16812-104PowderBulk ingredients for compoundingOctober 16, 2024
Fluticasone furoate16812-007PowderBulk ingredientsJuly 31, 2023
Semaglutide16812-103PowderBulk ingredients for compoundingJune 30, 2023
Semaglutide16812-103PowderBulk ingredientsJune 30, 2023
Semaglutide16812-103PowderBulk ingredientsJune 30, 2023
Semaglutide16812-103PowderBulk ingredients for compoundingJune 30, 2023
Semaglutide16812-103PowderBulk ingredients for compoundingJune 30, 2023

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.